• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number UNK-NV-ONYX
Device Problem Entrapment of Device (1212)
Patient Problems Therapeutic Response, Decreased (2271); Device Embedded In Tissue or Plaque (3165)
Event Date 04/14/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Pulli, benjamin, christopher j.Stapleton, brian p.Walcott, matthew j.Koch, scott b.Raymond, thabele m.Leslie-mazwi, james d.Rabinov, and aman b.Patel.2020.'comparison of predictive grading systems for procedural risk in endovascular treatment of brain arteriovenous malformations: analysis of 104 consecutive patients'.Journal of neurosurgery 133 (2): 342¿50.Http://search.Ebscohost.Com/login.Aspx?direct=true<(>&<)>authtype=shib <(>&<)>db=edo<(>&<)>an=144979786<(>&<)>site=eds-live.Medtronic received a literature report pertaining to patients underwent adjunctive endovascular embolization of brain avms between 2002 and 2016 with the goal of reducing the surgical or hemorrhagic risk before definitive radiosurgical treatment.Ten major and 16 minor complications were encountered in 24 patients.A total of 104 patients were included, 45 female, average age of 43 years.Onyx was used in 68 of the total patients.Balloon-assisted onyx delivery with a scepter balloon catheter was utilized in 3 patients.There were also five instances of microcatheter break or retention with the marathon microcatheter and onyx.Toward the end of the study period, the physician s witched to the apollo detachable-tip microcatheter and have not encountered additional instances of microcatheter break, or retention since then.It was noted that there were onyx related complications, but the article did not specify which type of complications as they pertain to onyx.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
7635140379
MDR Report Key10814535
MDR Text Key217647375
Report Number2029214-2020-01111
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNK-NV-ONYX
Device Catalogue NumberUNK-NV-ONYX
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/15/2020
Initial Date FDA Received11/09/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age43 YR
-
-